Other headlines:Amicas revenues flattenFormer Vital chief joins Streamline board
Computer-aided detection specialist iCAD reported record year-end revenues and profit, but much of the growth in fiscal 2008 ebbed in the fourth quarter. The company deferred guidance on the first half of 2009, citing the "challenging economic environment and associated uncertainty in the healthcare markets." A 41% leap in annual revenue to $37.5 million contrasted sharply with the fourth quarter's revenue of $9.3 million, representing a 15% increase over the year-earlier period. Annual net income of $4.4 million compared with a net of $321,000 in 4Q 08. Revenue growth for 2008 was paced by booming sales of digital mammography equipment. Demand for this equipment is now dropping. iCAD is seeking to broaden its revenue stream with software packages for breast and prostate MR, as well as CT colonography.
Revenues at PACS/IT vendor Amicas were flat for the fourth quarter at $11.7 million compared with the year-earlier period. The company absorbed a net loss in the period of $28.7 million, or $0.81 per share, due largely to an impairment charge of $27.5 million -- $27.3 million due to goodwill write-offs and $0.2 million due to internal purchase of software. The 4Q loss compares with a net loss of $902,000, or $0.02 per share, for the year-earlier period. Total revenue for the year ended Dec. 31, 2008, was $50.4 million, compared with $49.9 million for the previous year. At the end of 2008, Amicas had $55 million in cash, no long-term debt, and working capital of $47 million. The company has offered $39 million to purchase PACS/IT vendor Emageon.
Jay D. Miller has taken a seat on the board of directors at Streamline Health Solutions. From 2002 to 2008, Miller served as president and CEO of Vital Images, a provider of advanced visualization software. Streamline Health supplies tools for automating and otherwise improving the efficiency of handling documents.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.